PAH Today: Shape the Future

The phaware® interview

SPECIAL EDITION PHAWARE® PODCAST: How Decisions Today Can Shape the Future

The PAH Initiative and United Therapeutics are excited to bring you the PAH Today National Broadcast Series. This series of virtual events is intended for adult patients with pulmonary arterial hypertension (PAH) and their caregivers.

Advancements in the care and treatment of PAH are improving the lives of those impacted by this life-threatening disease. The National Broadcast Series will include insights and perspectives on today’s approaches to managing PAH from nationally recognized PAH healthcare providers. Join patients and caregivers across the nation to hear current considerations in the care of PAH.

This is the second of 4 PAH Today broadcasts to learn about risk status, an important part of today’s approach to treating PAH. You’ll hear how risk status gives your healthcare provider a new way to assess your progress, and how it could help determine whether more can be done to improve your symptoms today and down the road. Presented by Dr. Lana Melendres-Groves the Director of the Pulmonary Hypertension Program at the University of New Mexico and Nurse Practitioner Melisa Wilson. Learn more at: www.pahinitiative.com

Lana Melendres-Groves, MD:
Good afternoon, and welcome to the PAH Today National Broadcast Series: How Decisions Today Can Shape the Future. First, I would like to give a disclaimer that this presentation is sponsored by and made on behalf of United Therapeutics. Healthcare professional speakers are compensated by UT. Not all drugs are appropriate for all patients. Speak with your healthcare professional to determine which treatment plan is right for you. Patient experiences relayed during this program may not represent the experience of all patients.

Today’s presentation consists of three parts. The first is talking about what’s beyond being stable, which at times can be a very difficult concept to understand. I like to recommend to my patients…